公开(公告)号：WO2008005368A2

公开(公告)日：2008-01-10

申请号：PCT/US2007015192

申请日：2007-06-29

Applicant: ABBOTT LAB ,  BETSCHMANN PATRICK ,  CARROLL WILLIAM A ,  ERICSSON ANNA M ,  FIX-STENZEL SHANNON R ,  FRIEDMAN MICHAEL ,  HIRST GAVIN C ,  JOSEPHSOHN NATHAN S ,  LI BIQIN ,  PEREZ-MEDRANO ARTURO ,  MORYTKO MICHAEL J ,  RAFFERTY PAUL ,  CHEN HAIPENG

Inventor： BETSCHMANN PATRICK ,  CARROLL WILLIAM A ,  ERICSSON ANNA M ,  FIX-STENZEL SHANNON R ,  FRIEDMAN MICHAEL ,  HIRST GAVIN C ,  JOSEPHSOHN NATHAN S ,  LI BIQIN ,  PEREZ-MEDRANO ARTURO ,  MORYTKO MICHAEL J ,  RAFFERTY PAUL ,  CHEN HAIPENG

IPC: A61K31/496

CPC classification number: C07D241/04 ,  C07D241/36 ,  C07D295/215 ,  C07D401/06 ,  C07D401/12 ,  C07D401/14 ,  C07D403/04 ,  C07D403/06 ,  C07D403/12 ,  C07D403/14 ,  C07D405/06 ,  C07D405/12 ,  C07D405/14 ,  C07D409/06 ,  C07D409/12 ,  C07D409/14 ,  C07D413/04 ,  C07D413/06 ,  C07D413/12 ,  C07D413/14 ,  C07D417/04 ,  C07D417/06 ,  C07D417/12 ,  C07D417/14 ,  C07D471/04 ,  C07D487/04 ,  C07D495/04 ,  C07D498/04 ,  C07D513/04

Abstract: Novel compounds of Formula (I) or pharmaceutically acceptable salts thereof, metabolites thereof, isomers thereof, enantiomers thereof or prodrugs thereof of Formula (I), wherein the substituents are as defined herein, which are useful as therapeutic agents.

Abstract translation: 式（I）的新型化合物或其药学上可接受的盐，其代谢物，其异构体，其对映异构体或其前体药物，其中取代基如本文所定义，其可用作治疗剂。

公开(公告)号：WO2007117465A3

公开(公告)日：2008-08-28

申请号：PCT/US2007008307

申请日：2007-04-02

Applicant: ABBOTT LAB ,  ERICSSON ANNA M ,  BURCHAT ANDREW ,  FRANK KRISTINE E ,  CALDERWOOD DAVID J ,  ABBOTT LILY K ,  ARGIRIADI MARIA A ,  BORHANI DAVID W ,  CUSACK KEVIN P ,  DIXON RICHARD W ,  GORDON THOMAS D ,  MULLEN KELLY D ,  TALANIAN ROBERT V ,  WU XIAOYUN ,  ZHANG XIAOLEI ,  WANG LU X ,  LI BIQIN ,  BARBERIS CLAUDE E ,  WISHART NEIL

Inventor： ERICSSON ANNA M ,  BURCHAT ANDREW ,  FRANK KRISTINE E ,  CALDERWOOD DAVID J ,  ABBOTT LILY K ,  ARGIRIADI MARIA A ,  BORHANI DAVID W ,  CUSACK KEVIN P ,  DIXON RICHARD W ,  GORDON THOMAS D ,  MULLEN KELLY D ,  TALANIAN ROBERT V ,  WU XIAOYUN ,  ZHANG XIAOLEI ,  WANG LU X ,  LI BIQIN ,  BARBERIS CLAUDE E ,  WISHART NEIL

IPC: A61K31/5377

CPC classification number: C07D487/04 ,  C07D403/12 ,  C07D403/14 ,  C07D409/04 ,  C07D409/14

Abstract: Novel compounds of Formula (I) or pharmaceutically acceptable salts, prodrugs and biologically active metabolites thereof of Formula (I) wherein the substituents are as defined herein, which are useful as therapeutic agents.

Abstract translation: 式（I）的新型化合物或其药学上可接受的盐，前体药物和式（I）的生物活性代谢物，其中取代基如本文所定义，其可用作治疗剂。

公开(公告)号：WO2008060621A2

公开(公告)日：2008-05-22

申请号：PCT/US2007024076

申请日：2007-11-16

Applicant: ABBOTT LAB ,  GEORGE DAWN M ,  DIXON RICHARD W ,  FRIEDMAN MICHAEL ,  HOBSON ADRIAN ,  LI BIQIN ,  WANG LU ,  WU XIAOYUN ,  WISHART NEIL

Inventor： GEORGE DAWN M ,  DIXON RICHARD W ,  FRIEDMAN MICHAEL ,  HOBSON ADRIAN ,  LI BIQIN ,  WANG LU ,  WU XIAOYUN ,  WISHART NEIL

IPC: C07D471/04 ,  A61K31/4375 ,  A61K31/438 ,  A61K31/454 ,  C07D401/04

CPC classification number: A61K31/454 ,  A61K31/437 ,  A61K31/438 ,  A61K31/4545 ,  A61K31/4709 ,  A61K31/4747 ,  A61K31/506 ,  A61K31/517 ,  A61K31/5377 ,  A61K31/55 ,  A61K31/553 ,  C07D207/14 ,  C07D401/04 ,  C07D401/14 ,  C07D403/12 ,  C07D405/14 ,  C07D413/14 ,  C07D417/14 ,  C07D471/04 ,  C07D471/10 ,  C07D487/04 ,  C07D487/10 ,  C07D487/14

Abstract: The present invention is directed to novel aminopyrrolidines of formula I, pharmaceutically acceptable salts thereof, metabolites thereof, isomers thereof, stereoisomers thereof or pro-drugs thereof, wherein the variables are as defined herein. The compounds of formula (I) are useful as chemokine receptor antagonists and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases and proliferative disorders and conditions, for example, cancers.

Abstract translation: 本发明涉及式I的新型氨基吡咯烷，其药学上可接受的盐，其代谢物，其异构体，其立体异构体或其前体药物，其中变量如本文所定义。 式（I）化合物可用作趋化因子受体拮抗剂，因此可用于治疗某些病症和疾病，特别是炎性病症和疾病以及增殖性疾病和病症，例如癌症。

公开(公告)号：EP2001480A4

公开(公告)日：2011-06-15

申请号：EP07754773

申请日：2007-04-02

Applicant: ABBOTT LAB

Inventor： ERICSSON ANNA M ,  BURCHAT ANDREW ,  FRANK KRISTINE E ,  CALDERWOOD DAVID J ,  ABBOTT LILY K ,  ARGIRIADI MARIA A ,  BORHANI DAVID W ,  CUSACK KEVIN P ,  DIXON RICHARD W ,  GORDON THOMAS D ,  MULLEN KELLY D ,  TALANIAN ROBERT V ,  WU XIAOYUN ,  ZHANG XIAOLEI ,  WANG LU X ,  LI BIQIN ,  BARBERIS CLAUDE E ,  WISHART NEIL

IPC: A61K31/196 ,  A61P35/00 ,  C07D403/12

CPC classification number: C07D487/04 ,  C07D403/12 ,  C07D403/14 ,  C07D409/04 ,  C07D409/14

公开(公告)号：EP2203051A4

公开(公告)日：2011-09-07

申请号：EP08834489

申请日：2008-09-25

Applicant: ABBOTT LAB

Inventor： GEORGE DAWN M ,  WANG LU ,  LI BIQIN ,  ERICSSON ANNA M ,  ANSELL GRAHAM K

IPC: A01N37/18 ,  A61K31/165 ,  C07D211/14 ,  C07D295/185 ,  C07D309/14 ,  C07D405/12 ,  C07D471/04

CPC classification number: C07D471/04 ,  C07D211/14 ,  C07D295/185 ,  C07D309/14 ,  C07D405/12

公开(公告)号：EP2099454A4

公开(公告)日：2010-11-10

申请号：EP07867491

申请日：2007-11-16

Applicant: ABBOTT LAB

Inventor： GEORGE DAWN M ,  DIXON RICHARD W ,  FRIEDMAN MICHAEL ,  HOBSON ADRIAN ,  LI BIQIN ,  WANG LU ,  WU XIAOYUN ,  WISHART NEIL

IPC: A61K31/445 ,  C07D211/00

CPC classification number: A61K31/454 ,  A61K31/437 ,  A61K31/438 ,  A61K31/4545 ,  A61K31/4709 ,  A61K31/4747 ,  A61K31/506 ,  A61K31/517 ,  A61K31/5377 ,  A61K31/55 ,  A61K31/553 ,  C07D207/14 ,  C07D401/04 ,  C07D401/14 ,  C07D403/12 ,  C07D405/14 ,  C07D413/14 ,  C07D417/14 ,  C07D471/04 ,  C07D471/10 ,  C07D487/04 ,  C07D487/10 ,  C07D487/14

公开(公告)号：BRPI0811065A2

公开(公告)日：2014-12-02

申请号：BRPI0811065

申请日：2008-06-04

Applicant: ABBOTT LAB ,  ABBOTT GMBH & CO KG

Inventor： AKRITOPOULOU-ZANZE IRINI ,  WAKEFIELD BRIAN D ,  MACK HELMUT ,  TURNER SEAN C ,  GASIECKI ALAN F ,  GRACIAS VIJAVA J ,  SARRIS KATHY ,  KALVIN DOUGLAS M ,  MICHMERHUIZEN MELISSA J ,  SHUAI QI ,  PATEL JYOTI R ,  BAKKER MARGARETHA ,  TEUSCH NICOLE ,  JOHNSON ERIC F ,  KOVAR PETER J ,  DJURIC STEVAN W ,  LONG ANDREW J ,  VASUDEVAN ANIL ,  HOBSON ADRIAN ,  MOORE NIGEL ST JOHN ,  WANG LU ,  GEORGE DAWN ,  LI BIQIN ,  FRANK KRISTINE

IPC: C07D403/04 ,  C07D413/04 ,  C07D417/04

公开(公告)号：CA2689117A1

公开(公告)日：2008-12-18

申请号：CA2689117

申请日：2008-06-04

Applicant: ABBOTT GMBH & CO KG ,  ABBOTT LAB

Inventor： WAKEFIELD BRIAN D ,  AKRITOPOULOU-ZANZE IRINI ,  MACK HELMUT ,  FRANK KRISTINE ,  LI BIQIN ,  VASUDEVAN ANIL ,  HOBSON ADRIAN ,  LONG ANDREW J ,  DJURIC STEVAN W ,  KOVAR PETER J ,  JOHNSON ERIC T ,  TURNER SEAN C ,  GEORGE DAWN ,  GASIECKI ALAN F ,  WANG LU ,  ST JOHN MOORE NIGEL ,  MICHMERHUIZEN MELISSA J ,  GRACIAS VIJAYA J ,  SARRIS KATHY ,  KALVIN DOUGLAS M ,  SHUAI QI ,  PATEL JYOTI R ,  BAKKER MARGARETHA ,  TEUSCH NICOLE

IPC: C07D403/04 ,  C07D413/04 ,  C07D417/04

Abstract: The present invention relates to compounds of formula (I) or pharmaceutic al acceptable salts, wherein A, R1, R2, R3 and m, are defined in the descrip tion. The present invention relates also to methods of making said compounds , and compositions containing said compounds which are useful for inhibiting kinases such as Glycogen Synthase kinase 3 (GSK-3), Rho kinase (ROCK), Janu s Kinases (JAK), AKT, PAK4, PLK, CK2, KDR, MK2, JNK1, aurora, pim 1 and nek 2.

公开(公告)号：CA2644910C

公开(公告)日：2014-01-28

申请号：CA2644910

申请日：2007-04-02

Applicant: ABBOTT LAB

Inventor： ERICSSON ANNA M ,  BURCHAT ANDREW ,  FRANK KRISTINE E ,  CALDERWOOD DAVID J ,  ABBOTT LILY K ,  ARGIRIADI MARIA A ,  BORHANI DAVID W ,  CUSACK KEVIN P ,  DIXON RICHARD W ,  GORDON THOMAS D ,  MULLEN KELLY D ,  TALANIAN ROBERT V ,  WU XIAOYUN ,  ZHANG XIAOLEI ,  WANG LU X ,  LI BIQIN ,  BARBERIS CLAUDE E ,  WISHART NEIL

IPC: A61K31/5377

Abstract: Novel compounds of Formula (I) or pharmaceutically acceptable salts, prodrugs and biologically active metabolites thereof of Formula (I) wherein the substituents are as defined herein, which are useful as therapeutic agents.

公开(公告)号：MX2008012482A

公开(公告)日：2008-10-10

申请号：MX2008012482

申请日：2007-04-02

Applicant: ABBOTT LAB

Inventor： CALDERWOOD DAVID J ,  WISHART NEIL ,  DIXON RICHARD W ,  ERICSSON ANNA M ,  LI BIQIN ,  GORDON THOMAS D ,  BARBERIS CLAUDE E ,  TALANIAN ROBERT V ,  FRANK KRISTINE E ,  BURCHAT ANDREW ,  ABBOTT LILY K ,  ARGIRIADI MARIA A ,  BORHANI DAVID W ,  CUSACK KEVIN P ,  MULLEN KELLY D ,  WU XIAOYUN ,  ZHANG XIAOLEI ,  WANG LU X

IPC: A61K31/5377

Abstract: Se describen nuevos compuestos de fórmula (I) o sales farmacéuticamente aceptables, profármacos y metabilitos biológicamente activos de los mismos de fórmula (I), en donde los sustituyentes son según lo definido en la presente, los cuales son útiles como agentes terapéuticos.